Follow us
🗞️ News - October 8, 2024

£1.2 Million Grant for AI-Driven Early Detection of Arthritis

AI-driven system aims to enhance early detection of arthritis, improving patient outcomes and reducing healthcare costs. 🤖💉

🌟 Stay Updated!
Join Dr. Ailexa’s channels to receive the latest insights in health and AI.

⚡ Quick Summary

Henley Business School has secured a £1.2 million grant aimed at developing a machine learning platform designed to enhance the early detection and referral processes for rheumatic and musculoskeletal diseases (RMD).

💡 Key Features and Objectives

  • 🔍 Project Name: The AI system, named RMD-Health, will be piloted at Royal Berkshire NHS Foundation Trust and Oxford University Hospitals NHS Foundation Trust between 2026 and 2027.
  • 💰 Funding Sources: The grant is provided by the National Institute for Health and Care Research (NIHR), the Engineering and Physical Sciences Research Council, and the Health Innovation Partnership.
  • 📊 Target Population: RMD affects up to one-third of the UK population and is a significant contributor to disability.

👩‍⚕️ Expert Insights

Professor Weizi (Vicky) Li, the project lead and a professor of informatics and digital health at Henley Business School, stated:

  • “The annual cost of sick leave and work-related disability for rheumatoid arthritis alone is estimated at £1.8 billion, highlighting the urgent need for improvement in the current referral system.”
  • “Our machine-learning system offers a novel approach to RMD referrals, allowing for more accurate and timely patient referrals, which can lead to faster and more effective treatments.”

🚑 Addressing Current Challenges

  • ⚠️ Referral Accuracy: Between 2019 and 2021, GPs had only 40% accuracy in early inflammatory arthritis referrals, placing a heavy burden on secondary care clinicians.
  • Delays in Treatment: Current delays in referrals often lead to repeated consultations with GPs and hinder timely access to appropriate treatments.

🌟 Project Goals and Collaboration

Dr. Antoni Chan, project co-lead and consultant rheumatologist at Royal Berkshire NHS FT, emphasized:

  • “This innovative project marks a significant advancement in early RMD detection and referral, promising better patient outcomes and reduced healthcare costs.”
  • “The tool has shown significantly higher accuracy than existing clinical criteria during trials.”

🔗 Collaborative Efforts

The project involves collaboration among:

  • Henley Business School
  • Royal Berkshire NHS Foundation Trust
  • RBFT Health Data Institute
  • Oxford University Hospitals NHS Foundation Trust
  • Health Innovation Oxford
  • Integrated Care Boards across Thames Valley, Buckinghamshire, Oxfordshire, and Berkshire West
  • Patient leaders and public stakeholders

📅 Future Developments

With the grant, the team anticipates being on track for regulatory approval within three years, paving the way for the integration of RMD-Health into the NHS.

🔗 Sources


Stay updated with the latest news in health AI & digital health tech by following our website.

Image credit: assets.henley.ac.uk

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.